Signal Transducer and Activator of Transcription 5b Promotes Mucosal Tolerance in Pediatric Crohn's Disease and Murine Colitis
- 31 December 2006
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 169 (6), 1999-2013
- https://doi.org/10.2353/ajpath.2006.060186
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health-supported Children's Hospital Research Foundation Digestive Diseases Research and Development Center (R24 DK64403)
This publication has 54 references indexed in Scilit:
- Tumour necrosis factor blockade induces an anti-inflammatory growth hormone signalling pathway in experimental colitisGut, 2007
- Peroxisome proliferator activated receptor in colonic epithelial cells protects against experimental inflammatory bowel diseaseGut, 2005
- Dissection of the Inflammatory Bowel Disease Transcriptome Using Genome-Wide cDNA MicroarraysPLoS Medicine, 2005
- Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel DiseaseJournal of Clinical Microbiology, 2005
- Growth Hormone Receptor Is a Target for Presenilin-dependent γ-Secretase CleavagePublished by Elsevier BV ,2005
- Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5bToxicology and Applied Pharmacology, 2004
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003
- A novel PPARγ gene therapy to control inflammation associated with inflammatory bowel disease in a murine modelGastroenterology, 2003
- STAT5b-deficient Mice Are Growth Hormone Pulse-resistantPublished by Elsevier BV ,1999
- Beneficial effects of growth hormone combined with parenteral nutrition in the management of inflammatory bowel disease: An experimental studySurgery, 1997